XSWX:SANN (Switzerland)  
Santhera Pharmaceuticals Holding AG logo

Santhera Pharmaceuticals Holding AG

CHF 0.52 (+0.19%) Nov 30
P/E:
At Loss
P/B:
0
Market Cap:
CHF 28.31M ($ 29.97M)
Enterprise V:
CHF 56.26M ($ 59.55M)
Volume:
362.26K
Avg Vol (2M):
146.57K
Also Trade In:
Volume:
362.26K
Market Cap CHF:
28.31M
Market Cap $:
29.97M
PE Ratio:
At Loss
Avg Vol (2-Month):
146.57K
Enterprise Value CHF:
56.26M
Enterprise Value $:
59.55M
PB Ratio:
0
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area which includes many orphan and niche indications with high unmet medical need. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary and neuromuscular diseases. The company derives most of its revenue from the European Union.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.31
Equity-to-Asset -0.17
Debt-to-Equity -2.94
Debt-to-EBITDA -0.87
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.86
Distress
Grey
Safe
Beneish M-Score -4.31
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 13.01
9-Day RSI 22.47
14-Day RSI 28.71
6-1 Month Momentum % -51.88
12-1 Month Momentum % -49.37

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.38
Quick Ratio 0.37
Cash Ratio 0.33
Days Inventory 36.32
Days Sales Outstanding 3514.15
Days Payable 348.56

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -67.2

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 0.163
EPS (TTM) (CHF) -1.226
Beta 1.78
Volatility % 42.41
14-Day RSI 28.71
14-Day ATR (CHF) 0.035257
20-Day SMA (CHF) 0.5657
12-1 Month Momentum % -49.37
52-Week Range (CHF) 0.518 - 1.7
Shares Outstanding (Mil) 54.24

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Santhera Pharmaceuticals Holding AG Filings

Document Form Filing Date
No Filing Data

Santhera Pharmaceuticals Holding AG Analysis

Share your research